The Russian Direct Investment Fund (RDIF) has signed an agreement with leading Turkish pharmaceutical companies to produce in Turkey the Russian Sputnik V vaccine against the coronavirus, RIA Novosti reported.
"The potential volume of production of the Sputnik V vaccine is up to one million doses per year, the issue of expansion of production in the future is also being discussed. The vaccine will be supplied both in Turkey’s domestic market and in other countries," RDIF informed.
